Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
Plasmid quantity:
- 10mg, 50mg, 100mg, 500mg, >1g
Talk to our Expert:
- • Research Grade
- • Endotoxin-Free Grade
- • High Quality (HQ) Grade
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human MUC1/CD227/EMA ORF/cDNA clone-Adenovirus plasmid (BC120975)
Cat. No.: pGMAP000530
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human MUC1/CD227/EMA adenoviral expression plasmid for MUC1 adenovirus packaging, MUC1 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Datasheet
Go to
MUC1/CA15-3/CA15-3 C-terminal/CD227/MUC1/CD227 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAP000530 |
| Gene Name | MUC1 |
| Accession Number | BC120975 |
| Gene ID | 4582 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 795 bp |
| Gene Alias | CD227,EMA,H23AG,MAM6,PEM,PEMT |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACACCGGGCACCCAGTCTCCTTTCTTCCTGCTGCTGCTCCTCACAGTGCTTACAGCTACCACAGCCCCTAAACCCGCAACAGTTGTTACGGGTTCTGGTCATGCAAGCTCTACCCCAGGTGGAGAAAAGGAGACTTCGGCTACCCAGAGAAGTTCAGTGCCCAGCTCTACTGAGAAGAATGCTTTTAATTCCTCTCTGGAAGATCCCAGCACCGACTACTACCAAGAGCTGCAGAGAGACATTTCTGAAATGTTTTTGCAGATTTATAAACAAGGGGGTTTTCTGGGCCTCTCCAATATTAAGTTCAGGCCAGGATCTGTGGTGGTACAATTGACTCTGGCCTTCCGAGAAGGTACCATCAATGTCCACGACGTGGAGACACAGTTCAATCAGTATAAAACGGAAGCAGCCTCTCGATATAACCTGACGATCTCAGACGTCAGCGTGAGTGATGTGCCATTTCCTTTCTCTGCCCAGTCTGGGGCTGGGGTGCCAGGCTGGGGCATCGCGCTGCTGGTGCTGGTCTGTGTTCTGGTTGCGCTGGCCATTGTCTATCTCATTGCCTTGGCTGTCTGTCAGTGCCGCCGAAAGAACTACGGGCAGCTGGACATCTTTCCAGCCCGGGATACCTACCATCCTATGAGCGAGTACCCCACCTACCACACCCATGGGCGCTATGTGCCCCCTAGCAGTACCGATCGTAGCCCCTATGAGAAGGTTTCTGCAGGTAATGGTGGCAGCAGCCTCTCTTACACAAACCCAGCAGTGGCAGCCACTTCTGCCAACTTGTAG |
| ORF Protein Sequence | MTPGTQSPFFLLLLLTVLTATTAPKPATVVTGSGHASSTPGGEKETSATQRSSVPSSTEKNAFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPGSVVVQLTLAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIALAVCQCRRKNYGQLDIFPARDTYHPMSEYPTYHTHGRYVPPSSTDRSPYEKVSAGNGGSSLSYTNPAVAATSANL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-T18779 |
| Target Name | MUC1/CA15-3/CA15-3 C-terminal/CD227 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
4582 |
| Gene ID |
100063415 (Equus caballus), 101093832 (Felis catus), 17829 (Mus musculus), 24571 (Rattus norvegicus) 281333 (Bos taurus), 448784 (Canis lupus familiaris), 4582 (Homo sapiens), 717546 (Macaca mulatta) |
| Gene Symbols & Synonyms | MUC1,Muc1,EMA,CD227,Muc-1,mucin,MCD,PEM,PUM,KL-6,MAM6,MCKD,PEMT,H23AG,MCKD1,MUC-1,ADMCKD,ADTKD2,Ca15-3,ADMCKD1,CA 15-3,MUC-1/X,MUC1/ZD,MUC-1/SEC |
| Target Alternative Names | ADMCKD,ADMCKD1,ADTKD2,Breast carcinoma-associated antigen DF3,CA 15-3,CA15-3,CA15-3 C-terminal,CD227,Ca15-3,Cancer antigen 15-3 (CA 15-3),Carcinoma-associated mucin,EMA,Episialin,H23AG,KL-6,Krebs von den Lungen-6 (KL-6),MAM6,MCD,MCKD,MCKD1,MUC-1,MUC-1/SEC,MUC-1/X,MUC1,MUC1/ZD,Muc-1,Muc1,Mucin-1,PEM,PEMT,PUM,Peanut-reactive urinary mucin (PUM),Polymorphic epithelial mucin (PEM),Tumor-associated epithelial membrane antigen (EMA),Tumor-associated mucin,mucin |
| Uniprot Accession |
P15941,Q02496,Q8WML4
Additional SwissProt Accessions: Q02496,Q8WML4,P15941 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index |
| Disease | cancer, Ovary Cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000006646, ENSMUSG00000042784, ENSBTAG00000017104, ENSCAFG00845013058, ENSG00000185499 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.